Ring-enhancing brain lesions (REBL) represent a significant portion of a neuroradiologist’s daily practice, encompassing both benign and malignant lesions of various origins. REBL encompasses brain abscesses (BA), as well as primary and secondary brain cancers, predominantly metastases and glioblastomas [1]. BA exhibits a prevalence of 0.3–1.3 per ten thousand individuals annually, with a significant incidence of 8 % in underdeveloped nations. BA exhibits a one-year mortality rate of 21 %. This …